Drug comparisons
Dapagliflozin vs Rosiglitazone
Compare Dapagliflozin (Farxiga) and Rosiglitazone for type 2 diabetes. Differences in heart benefits, kidney protection, side effects, and usage.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when choosing an add-on oral agent for type 2 diabetes patients with cardiovascular risk or heart failure concerns.
Bottom line
Dapagliflozin is typically favored over rosiglitazone for most patients due to organ-protective effects, though selection must be individualized.
All medication comparisons